A carregar...
Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
Given the speed of viral infection spread, repurposing of existing drugs has been given the highest priority in combating the ongoing COVID-19 pandemic. Only drugs that are already registered or close to registration, and therefore have passed lengthy safety assessments, have a chance to be tested i...
Na minha lista:
| Publicado no: | Biomed Pharmacother |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Author(s). Published by Elsevier Masson SAS.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7392152/ https://ncbi.nlm.nih.gov/pubmed/32763818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2020.110582 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|